BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
BMY.RT
Delisted
BMY.RT was delisted on the 31st of December, 2020.
615 hedge funds and large institutions have $1.57B invested in Bristol-Myers Squibb Company Contingent Value Rights in 2019 Q4 according to their latest regulatory filings, with 615 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
615
Holders Change
+615
Holders Change %
–
% of All Funds
12.14%
Holding in Top 10
8
Holding in Top 10 Change
+8
Holding in Top 10 Change %
%
% of All Funds
0.16%
New
615
Increased
–
Reduced
–
Closed
–
Calls
$48M
Puts
$8.03M
Net Calls
+$39.9M
Net Calls Change
+$39.9M
Top Buyers
Top Sellers
No sellers this quarter